Seasonal rhinitis and azelastine: Long- or short-term treatment

Slides:

Advertisements

Similar presentations

Reducing relative humidity to control the house dust mite Dermatophagoides farinae Larry G. Arlian, PhD, Jacqueline S. Neal, BS, DiAnn L. Vyszenski-Moher,

Advertisements

Control of airborne latex by use of powder-free latex gloves

Daniela P. Metz, PhDa, Annette S

Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy Monica B. Arvidsson, MD, Olle.

Shin-Ichi Nishikawa, MD, PhD

Relationship of nasal carriage of Staphylococcus aureus to pathogenesis of perennial allergic rhinitis Teruo Shiomori, MDa, Shin-ichi Yoshida, MD, PhDb,

Serum cytotoxic T lymphocyte–associated antigen 4 in Hymenoptera venom allergy and its modulation by specific immunotherapy Daniele Saverino, BS, Anna.

Jay A. Lieberman, MD, Faith R. Huang, MD, Hugh A

Epicutaneous allergen-specific immunotherapy ameliorates grass pollen–induced rhinoconjunctivitis: A double-blind, placebo-controlled dose escalation.

Absorption and distribution kinetics of the major Parietaria judaica allergen (Par j 1) administered by noninjectable routes in healthy human beings

The effect of omalizumab on nasal allergic inflammation

Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis Paul H. Ratner,

Youngil I. Koh, MD a, Inseon S

Practice Notes from the AAAI

Badrul A. Chowdhury, MD, PhD

Hydroxychloroquine improves airflow and lowers circulating IgE levels in subjects with moderate symptomatic asthma B.Lauren Charous, MD, Elkan F. Halpern,

Comparison of the effects of terfenadine with fexofenadine on nasal provocation tests with allergen Maria-Helena Terrien, MD, François Rahm, MD, Jean-Marc.

Chronic sinusitis in severe asthma is related to sputum eosinophilia

Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis James.

As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis Albert Jen, MD, Fuad Baroody, MD, Marcy de Tineo,

Noninjection routes for immunotherapy

Nasal allergen provocation test with multiple aeroallergens detects polysensitization in local allergic rhinitis Carmen Rondón, MD, PhD, Paloma Campo,

Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis

Elephantiasis nostras: A case report

The impact of allergic rhinitis on bronchial asthma

Conjunctivitis medicamentosa

Topical azelastine reduces eosinophil activation and intercellular adhesion molecule-1 expression on nasal epithelial cells: An antiallergic activity

Side effects of inhaled corticosteroids

Practice Notes from the AAAAI

Effect of intranasal azelastine and beclomethasone dipropionate on nasal symptoms, nasal cytology, and bronchial responsiveness to methacholine in allergic.

A dose-ranging study of the efficacy and safety of azelastine nasal spray in the treatment of seasonal allergic rhinitis with an acute model John M.

A review of the current guidelines for allergic rhinitis and asthma

Physician-targeted program on inhaled therapy for childhood asthma

Pathophysiology of the inflammatory response

News & Notes Journal of Allergy and Clinical Immunology

IgE autoantibodies monitored in a patient with atopic dermatitis under cyclosporin A treatment reflect tissue damage Tamar Kinaciyan, MD a*, Susanne.

Inflammatory cells, cytokine and chemokine expression in asthma immunocytochemistry and in situ hybridization Qutayba Hamid, MD, PhD, Editor Journal.

Toll-like receptor 2–positive and Toll-like receptor 4–positive cells in adenoids of children exposed to passive smoking Antonio Ricci, MD, M. Antonietta.

Daniela P. Metz, PhDa, Annette S

Allergen-specific immunotherapy with recombinant grass pollen allergens Marek Jutel, MD, Lothar Jaeger, MD, Roland Suck, PhD, Hanns Meyer, Dipl Math,

Inflammatory cell and epithelial characteristics of perennial allergic and nonallergic rhinitis with a symptom history of 1 to 3 years’ duration Kawa.

Subjective and objective assessments in patients with seasonal allergic rhinitis: Effects of therapy with mometasone furoate nasal spray Eli O. Meltzer,

Model for outcomes assessment of antihistamine use for seasonal allergic rhinitis Robert P. Harvey, MD, Carolyn Comer, MD, Barbara Sanders, MD, Ross Westley,

News & Notes Journal of Allergy and Clinical Immunology

Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic.

Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: A randomized, double-blind, placebo-controlled study Giovanni B. Pajno,

Fractional analysis of sequential induced sputum samples during sputum induction: Evidence that different lung compartments are sampled at different time.

Loratadine reduces allergen-induced mucosal output of α2-macroglobulin and tryptase in allergic rhinitis Lennart Greiff, MD, PhDa, Carl G.A. Persson,

Chemokines in seasonal allergic rhinitis

Thomas E. Van Metre, MD, Gary L. Rosenberg, MD, Surender K

Charles V. Klucka, DO, Dennis R

Increased adhesion to vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 of eosinophils from patients with asthma Lena Håkansson,

Practice Notes from the AAAI

Intranasal administration of eotaxin increases nasal eosinophils and nitric oxide in patients with allergic rhinitis Toyoyuki Hanazawa, MD, PhD, Julio.

Corticosteroids in the treatment of pediatric allergic rhinitis

Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen–induced seasonal allergic rhinitis Ellinor Ädelroth, MD, PhDa, Sabina Rak, MD, PhDb,

Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways Gert-Jan Braunstahl, MDa, b, Shelley.

Thunderstorm-related asthma attacks

Long-lasting effects of sublingual immunotherapy according to its duration: A 15-year prospective study Maurizio Marogna, MD, Igino Spadolini, MD, Alessandro.

Abnormalities of cell and mediator levels in bronchoalveolar lavage fluid of patients with mild asthma Sally E. Wenzel, MD Journal of Allergy and Clinical.

Further studies on the chronotherapy of asthma with inhaled steroids: The effect of dosage timing on drug efficacy Diane J. Pincus, MD, Teresa R. Humeston,

Footnotes1 Journal of Allergy and Clinical Immunology

Evelyn Farinas, RPh, MGA, Peter Honig, MD

The environmental predictors of allergic disease

Relationship of nasal carriage of Staphylococcus aureus to pathogenesis of perennial allergic rhinitis Teruo Shiomori, MDa, Shin-ichi Yoshida, MD, PhDb,

Mechanism of topical glucocorticoid treatment of hay fever: IL-5 and eosinophil activation during natural allergen exposure are suppressed, but IL-4,

News & Notes Journal of Allergy and Clinical Immunology

Natural history of cow’s milk allergy

Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal.

Advances in mechanisms of allergic disease in 2016

Presentation transcript:

Seasonal rhinitis and azelastine: Long- or short-term treatment Giorgio Ciprandi, MD, Vittorio Ricca, MD, Giovanni Passalacqua, MD, Tiziana Truffeli, MD, Claudia Bertolini, MD, Nicola Fiorino, BS, Anna Maria Riccio, BS, Marcello Bagnasco, MD, Giorgio Walter Canonica, MD Journal of Allergy and Clinical Immunology Volume 99, Issue 3, Pages 301-307 (March 1997) DOI: 10.1016/S0091-6749(97)70046-0 Copyright © 1997 Mosby, Inc. Terms and Conditions

Fig. 1 Pollen count, clinical scores, and additional azelastine doses. Upper panel, Pollen count; middle panel, mean weekly score; lower panel, mean weekly supplementary doses. Journal of Allergy and Clinical Immunology 1997 99, 301-307DOI: (10.1016/S0091-6749(97)70046-0) Copyright © 1997 Mosby, Inc. Terms and Conditions

Fig. 1 Pollen count, clinical scores, and additional azelastine doses. Upper panel, Pollen count; middle panel, mean weekly score; lower panel, mean weekly supplementary doses. Journal of Allergy and Clinical Immunology 1997 99, 301-307DOI: (10.1016/S0091-6749(97)70046-0) Copyright © 1997 Mosby, Inc. Terms and Conditions

Fig. 1 Pollen count, clinical scores, and additional azelastine doses. Upper panel, Pollen count; middle panel, mean weekly score; lower panel, mean weekly supplementary doses. Journal of Allergy and Clinical Immunology 1997 99, 301-307DOI: (10.1016/S0091-6749(97)70046-0) Copyright © 1997 Mosby, Inc. Terms and Conditions

Fig. 2 Neutrophil count in nasal scraping in the three treatment groups at monthly visits. Intergroup comparison p values (Mann-Whitney test) are indicated above the bars. Journal of Allergy and Clinical Immunology 1997 99, 301-307DOI: (10.1016/S0091-6749(97)70046-0) Copyright © 1997 Mosby, Inc. Terms and Conditions

Fig. 3 Eosinophil count in nasal scraping in the three treatment groups at monthly visits. Intergroup comparison p values (Mann-Whitney test) are indicated above the bars. Journal of Allergy and Clinical Immunology 1997 99, 301-307DOI: (10.1016/S0091-6749(97)70046-0) Copyright © 1997 Mosby, Inc. Terms and Conditions

Fig. 4 ICAM-1 positivity on nasal epithelial cells in the three treatment groups at monthly visits. Intergroup comparison p values (Mann-Whitney test) are indicated above the bars. Journal of Allergy and Clinical Immunology 1997 99, 301-307DOI: (10.1016/S0091-6749(97)70046-0) Copyright © 1997 Mosby, Inc. Terms and Conditions